BioNTech SE (BNTX)
92.72
+0.48
(+0.52%)
USD |
NASDAQ |
May 03, 16:00
94.00
+1.28
(+1.38%)
After-Hours: 20:00
BioNTech Cash and Short Term Investments (Quarterly): 18.29B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.29B |
| September 30, 2023 | 16.67B |
| June 30, 2023 | 16.91B |
| March 31, 2023 | 13.63B |
| December 31, 2022 | 15.08B |
| September 30, 2022 | 13.20B |
| June 30, 2022 | 9.751B |
| March 31, 2022 | 6.881B |
| December 31, 2021 | 2.349B |
| September 30, 2021 | 2.777B |
| Date | Value |
|---|---|
| June 30, 2021 | 1.089B |
| March 31, 2021 | 1.046B |
| December 31, 2020 | 1.657B |
| September 30, 2020 | 1.184B |
| June 30, 2020 | 646.64M |
| March 31, 2020 | 499.98M |
| December 31, 2019 | 583.42M |
| September 30, 2019 | 507.29M |
| June 30, 2019 | 540.68M |
| December 31, 2018 | 471.09M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
499.98M
Minimum
Mar 2020
18.29B
Maximum
Dec 2023
6.489B
Average
2.349B
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Pfizer Inc | 12.69B |
| Moderna Inc | 8.523B |
| Autolus Therapeutics PLC | 239.57M |
| Novavax Inc | 568.50M |
| BioVie Inc | 20.23M |